Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07534995) titled 'A Prospective, Multicenter, Randomized, Parallel-controlled, Superiority Trial' on April 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Condition:
OIC
Intervention:
Drug: the Shouhui Tongbian Capsule
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: May 30, 2026
Target Sample Size: 270
To know more, visit https://clinicaltrials.gov/study/NCT07534995
Disclaimer: Cur...